HMG-COA REDUCTASE INHIBITORS SIGNIFICANTLY IMPROVE SURVIVAL IN CLINICAL LUNG TRANSPLANTATION, A RETROSPECTIVE ANALYSIS OF MORE THAN 500 PATIENTS